Psykofarmaka til patienter med glaukom

Karin Povlsen, Kenneth Skov, Miriam Kolko, Daniella Bach-Holm, Stig Ejdrup Andersen*

*Corresponding author af dette arbejde


This review offers a summary of the current knowledge of pshychotropic drugs and glaucoma. If exposed to psychotropic drugs, some patients may develop angle-closure glaucoma. Although rarely contraindicated, exposed predisposed and diagnosed patients should be followed-up by an ophthalmologist. It is still unclear if serotonin reuptake inhibitors increase the risk of angle-closure glaucoma. Tricyclic antidepressants and benzodiazepines should be used with caution in predisposed patients. The same applies to antipsychotic drugs, where first-generation antipsychotic drugs might have a smaller impact on the intraocular pressure than second-generation antipsychotic drugs.

Bidragets oversatte titelPsychotropic drugs for patients with glaucoma
TidsskriftUgeskrift for Laeger
Udgave nummer48
StatusUdgivet - 27 nov. 2023


  • Humans
  • Antipsychotic Agents/adverse effects
  • Glaucoma, Angle-Closure/chemically induced
  • Psychotropic Drugs
  • Glaucoma/chemically induced
  • Selective Serotonin Reuptake Inhibitors/adverse effects


Dyk ned i forskningsemnerne om 'Psykofarmaka til patienter med glaukom'. Sammen danner de et unikt fingeraftryk.